Catalyst Wire Dossier Catalyst Wire Dossier
FDA approval · 2017-11-01

FDA Approved: DUAVEE — Supplemental Application (Wyeth Pharmaceuticals LLC, a subsidiary of Pfizer Inc.)

View source ↗

Summary

The FDA approved a supplemental application for Duavee (conjugated estrogens/bazedoxifene) from Wyeth/Pfizer to update the product labeling for postmenopausal o…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Duavee (bazedoxifene/conjugated estrogens)

Snippet

SUPPL AP for DUAVEE (CONJUGATED ESTROGENS/BAZEDOXIFENE)